Jasper Therapeutics, Inc. (JSPR, JSPRW)

CIK 1788028 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Jasper Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 4, 2026DEF 14A0001213900-26-097572
Aug 26, 20268-K0001213900-26-093979
Aug 24, 2026PRE 14A0001213900-26-093145
Aug 17, 2026SCHEDULE 13G0000921895-26-002220
Aug 14, 20268-K0001213900-26-090055
Aug 14, 202610-Q0001213900-26-089592
Aug 5, 2026D0001213900-26-085315
Aug 4, 202640001213900-26-085190
Aug 4, 202640001213900-26-085191
Aug 4, 202640001213900-26-085192
Aug 4, 202640001213900-26-085188
Aug 4, 202640001213900-26-085189
Aug 3, 20268-K0001213900-26-084687
Jul 31, 20268-K0001213900-26-083563
Jul 23, 202630001213900-26-080864
Jul 22, 202630001213900-26-080524
Jul 22, 202640001213900-26-080525
Jul 22, 202630001213900-26-080523
Jul 20, 2026SCHEDULE 13D/A0000921895-26-001834
Jul 20, 202640001213900-26-079764
Jul 20, 202630001213900-26-079762
Jul 17, 20268-K0001213900-26-078887
Jul 16, 20268-K0001213900-26-078781
Jul 10, 2026SCHEDULE 13G/A0001104659-26-082738
Jun 15, 2026DEFA14A0001213900-26-068767